Celyad SA Sponsored ADR
(NASDAQ : CYAD)

( )
CYAD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MNKMallinckrodt Plc
-0.28%35.9721.1%$138.29m
PRGOPerrigo Co. Plc
-1.88%74.076.7%$126.06m
SHPGShire PLC Sponsored ADR
0.46%171.430.4%$113.20m
ENDPEndo International Plc
-1.95%15.608.9%$89.97m
JAZZJazz Pharmaceuticals Plc
-0.16%173.972.2%$72.74m
ICPTIntercept Pharmaceuticals, Inc.
3.50%107.0018.7%$69.26m
SAGESAGE Therapeutics, Inc.
3.81%153.879.6%$58.93m
UTHRUnited Therapeutics Corporation
2.46%128.1114.4%$52.33m
CTLTCatalent Inc
0.70%41.582.6%$48.31m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.41%137.496.8%$42.64m
PTLAPortola Pharmaceuticals, Inc.
1.20%25.327.7%$42.29m
SUPNSupernus Pharmaceuticals, Inc.
-0.11%44.356.2%$40.49m
ICLRICON Plc
1.41%143.944.2%$39.20m
ZGNXZogenix, Inc.
0.86%46.9011.9%$38.19m
HZNPHorizon Pharma plc
-0.63%20.507.4%$33.41m

Company Profile

Celyad SA is a clinical-stage biopharmaceutical company, which engages in the identification and development of specialized cell-based therapies. Its products include cardiopoiesis platform, immuno-oncology, and medical devices. The company was founded by Michel Lussier and William Wijns on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.